DAXXIFY® is an FDA approved neuromodulator to smooth moderate to severe lines between the brows. It is the only frown line treatment powered by a peptide.
The active ingredient in DAXXIFY® is a purified protein called botulinum toxin type A.
Until now, there never was an injectable wrinkle treatment formulated with a peptide.
The Daxxify® peptide helps stabilize the active ingredient, instead of using human blood products like conventional frown line treatments. It also has no animal byproducts.
The peptide also enhances attachment of the active ingredient, acting like a magnet and making more toxin available to enter nerve cells.
DAXXIFY® is the only prescription frown line treatment made in the United States. Created in California, it continues to be manufactured there today.
The safety and efficacy of DAXXIFY® is well established, with more than 20 years of research. In fact, DAXXIFY® has been studied in the largest-ever phase 3 clinical trial conducted for a frown line treatment and included more than 2,800 people across different ages and with different skin types. DAXXIFY® was studied in patients with varying skin types.
